Literature DB >> 15995577

Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.

Yolanda Jimenez-Soriano, Jose V Bagan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15995577

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN: 1698-4447


× No keyword cloud information.
  11 in total

1.  Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.

Authors:  Yasuyoshi Kobayashi; Toru Hiraga; Akimi Ueda; Liyang Wang; Michiyo Matsumoto-Nakano; Kenji Hata; Hirofumi Yatani; Toshiyuki Yoneda
Journal:  J Bone Miner Metab       Date:  2009-10-31       Impact factor: 2.626

2.  "Phossy Jaw" and "Bis-phossy Jaw" of the 19th and the 21st Centuries: The Diuturnity of John Walker and the Friction Match.

Authors:  Richard A Pollock; Ted W Brown; David M Rubin
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2015-07-24

Review 3.  Skeletal complications of breast cancer therapies.

Authors:  Angela Hirbe; Elizabeth A Morgan; Ozge Uluçkan; Katherine Weilbaecher
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

4.  Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: paradoxical complication of treatment of bone lesions in multiple myeloma patients.

Authors:  Silvana Capalbo; Mario Delia; Daniela Diomede; Michelina Dargenio; Antonia Chiefa; Gianfranco Favia; Vincenzo Liso
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

5.  Bisphosphonate-related osteonecrosis of the jaw: the Florence experience.

Authors:  Alberto Borgioli; Marco Duvina; Leila Brancato; Christian Viviani; Maria Luisa Brandi; Paolo Tonelli
Journal:  Clin Cases Miner Bone Metab       Date:  2007-01

Review 6.  Optimising antiresorptive therapies in postmenopausal women: why do we need to give due consideration to the degree of suppression?

Authors:  Morten A Karsdal; Per Qvist; Claus Christiansen; László B Tankó
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  Zoledronic acid and radiation: toxicity, synergy or radiosensitization?

Authors:  M Alcaraz; A Olivares; D Armero; M Alcaraz-Saura; D Achel
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

8.  Osteonecrosis of the jaws in 194 patients who have undergone intravenous bisphosphonate therapy in Spain.

Authors:  Carmen Vidal-Real; Mario Pérez-Sayáns; José-Manuel Suárez-Peñaranda; José-Manuel Gándara-Rey; Abel García-García
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-05-01

9.  Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations.

Authors:  Alberto Borgioli; Christian Viviani; Marco Duvina; Leila Brancato; Giuseppe Spinelli; Maria Luisa Brandi; Paolo Tonelli
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

10.  Bone metabolism and clinical study of 44 patients with bisphosphonate-related osteonecrosis of the jaws.

Authors:  María-Sacramento Bocanegra-Pérez; Mario Vicente-Barrero; Manuel Sosa-Henríquez; Eduardo Rodríguez-Bocanegra; José-María Limiñana-Cañal; Ariadna López-Márquez; Daniel Pérez-Plasencia; Angel Ramos-Macías
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.